- Home
- VVPR vs ENLV Comparison
VVPR vs ENLV Comparison
Compare VVPR & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VVPR | ENLV |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United Kingdom | Israel |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.2M | 26.6M |
| IPO Year | 2016 | 1995 |
Fundamental Metrics
Financial Performance| Metric | VVPR | ENLV |
|---|---|---|
| Price | $2.91 | $0.91 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 498.1K | ★ 11.5M |
| Earning Date | 01-01-0001 | 11-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $61,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 281.25 | N/A |
| 52 Week Low | $0.62 | $0.83 |
| 52 Week High | $8.88 | $2.10 |
Technical Indicators
Market Signals| Indicator | VVPR | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 48.56 | 43.10 |
| Support Level | $2.37 | $0.89 |
| Resistance Level | $2.78 | $1.25 |
| Average True Range (ATR) | 0.22 | 0.16 |
| MACD | 0.10 | -0.00 |
| Stochastic Oscillator | 60.00 | 5.26 |
Price Performance
Historical ComparisonAbout VVPR VivoPower International PLC
Vivopower International PLC is a sustainable energy solutions B Corporation specializing in electric solutions for customized and ruggedized fleet applications, battery and microgrids, solar, and critical power technology and services. The company's core purpose is to provide turnkey decarbonization solutions that help customers progress toward net-zero carbon status. VivoPower operates across five reportable segments: Electric Vehicles, Sustainable Energy Solutions, Solar Development, Digital Assets, and Corporate Office, with personnel and operations in Australia, the Netherlands, the United Kingdom, the United States, and the Philippines.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.